Astrana Health, Inc. Total Revenue

• Astrana Health, Inc. showed an increase of +56.4% in Total Revenue from 2024 to 2025.
• This data is from Astrana Health, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
• XBRL data for this metric is available from 2011 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q4 2012: $1.97 million | Q1 2013: $2.53 million | Q2 2013: $2.45 million | Q2 2013: $2.61 million | Q3 2013: $2.59 million | Q3 2013: $2.52 million | Q4 2013: $2.61 million | Q4 2013: $2.83 million | Q1 2014: $2.84 million | Q1 2014: $2.34 million | Q2 2014: $4.09 million | Q3 2014: $11.67 million | Q4 2014: $7.64 million | Q2 2015: $10.20 million | Q3 2015: $11.37 million | Q4 2015: $10.66 million | Q2 2016: $12.37 million | Q3 2016: $14.62 million | Q4 2016: $15.67 million | Q2 2017: $81.31 million | Q3 2017: $97.13 million | Q1 2018: $123.92 million | Q2 2018: $123.00 million | Q2 2018: $122.67 million | Q3 2018: $167.28 million | Q3 2018: $166.73 million | Q1 2019: $95.76 million | Q1 2019: $95.76 million | Q2 2019: $130.05 million | Q3 2019: $156.06 million | Q4 2019: $178.75 million | Q1 2020: $165.11 million | Q2 2020: $165.17 million | Q3 2020: $180.12 million | Q4 2020: $176.78 million | Q1 2021: $176.06 million | Q2 2021: $175.64 million | Q3 2021: $227.12 million | Q1 2022: $263.26 million | Q2 2022: $269.70 million | Q3 2022: $317.00 million | Q1 2023: $337.24 million | Q2 2023: $348.21 million | Q3 2023: $348.17 million | Q1 2024: $404.36 million | Q2 2024: $486.27 million | Q3 2024: $478.71 million | Q1 2025: $620.39 million | Q2 2025: $654.81 million | Q3 2025: $956.05 million.
• Over the full 18 years of available data (2011 to 2025), Astrana Health, Inc.'s Total Revenue has grown by 81,555.3%.
• Historical annual values: Fiscal year 2025: $3.18 billion | Fiscal year 2024: $2.03 billion | Fiscal year 2023: $1.39 billion | Fiscal year 2022: $1.14 billion | Fiscal year 2021: $773.92 million | Fiscal year 2020: $687.18 million | Fiscal year 2019: $560.62 million | Fiscal year 2018: $519.91 million | Fiscal year 2018: $519.91 million | Fiscal year 2017: $356.36 million | Fiscal year 2017: $356.36 million | Fiscal year 2017: $57.43 million | Fiscal year 2016: $44.05 million | Fiscal year 2015: $32.99 million | Fiscal year 2014: $10.48 million | Fiscal year 2013: $7.78 million | Fiscal year 2012: $5.11 million | Fiscal year 2011: $3.90 million.
• Data sourced from SEC EDGAR public filings as of August 6, 2026.

Last verified: August 6, 2026